Click here for slides on this topic


Very low-density lipoprotein (VLDL)

A plasma lipoprotein that is composed mainly of triglycerides and related apoprotein molecules (especially apo B and apo C). VLDL particles transport triglycerides and cholesterol from the liver for storage in and for use by peripheral tissues. Elevations in VLDL levels are commonly associated with obesity, insulin resistance and poorly controlled diabetes.


The following content matched the glossary term: Very low-density lipoprotein (VLDL)

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 9, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 9, 2012

Results from the EASIE, EUREXA, TODAY, and Diabetes Prevention Program (DPP) trials; new data on SGLT2 inhibitors for diabetes treatment, incretins for diabetes treatment, ATP-IV guideline update, and more.

 

Apolipoprotein E Kinetics: Influence of Insulin Resistance and Type 2 Diabetes

Top

Bach-Ngohou K, Ouguerram K, Nazih H, et al. Apolipoprotein E Kinetics: Influence of Insulin Resistance and Type 2 Diabetes. Int J Obesity. 2002;26:1451-1458. The aim of this study was to explore apoE kinetics of obese subjects and to determine what parameters could influence its metabolism.

Effect of Insulin and Sulfonylurea Therapy, at the Same Level of Blood Glucose Control, on Low Density Lipoprotein Subfractions

Top

Rivellese AA, Patti L, Romano G, et al. Effect of Insulin and Sulfonylurea Therapy, at the Same Level of Blood Glucose Control, on Low Density Lipoprotein Subfractions in Type 2 Diabetic Patients. J Clin Endocrinol Metab. 2000;85:4188-4192. The aim of this study was to evaluate the effect of sc insulin (INS) compared with sulfonylurea (SUL) therapy, at the same level of blood glucose control, on the low density lipoprotein (LDL) subfraction profile in normolipidemic type 2 diabetic patients.

Product Indications

Top

Medications used to treat diabetes :: Alpha-glucosidase inhibitors, amylin mimetics, biguanides (metformin), bile acid sequestrants, dopamine receptor agonists, DPP-4 inhibitors, GLP-1 analogs, incretins, insulin, meglitinides, SGLT2 inhibitors, sulphonylureas, thiazolidinediones (TZDs).



Slide Library Results

Search Results for: Very low-density lipoprotein (VLDL) Slides Found: 0